0001209191-13-031238.txt : 20130607
0001209191-13-031238.hdr.sgml : 20130607
20130607175226
ACCESSION NUMBER: 0001209191-13-031238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130604
FILED AS OF DATE: 20130607
DATE AS OF CHANGE: 20130607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0000786947
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 110853640
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
CITY: PALATINE
STATE: IL
ZIP: 60067
BUSINESS PHONE: 847-705-7709
MAIL ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
STREET 2: .
CITY: PALATINE
STATE: IL
ZIP: 60067
FORMER COMPANY:
FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALEN PARTNERS III L P
CENTRAL INDEX KEY: 0001034486
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 13901711
BUSINESS ADDRESS:
STREET 1: 610 FIFTH AVE
STREET 2: 5TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 2122184990
MAIL ADDRESS:
STREET 1: 610 FIFTH AVE
STREET 2: 5TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galen Management, LLC
CENTRAL INDEX KEY: 0001421162
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 13901712
BUSINESS ADDRESS:
BUSINESS PHONE: 203 654 6400
MAIL ADDRESS:
STREET 1: 680 WASHINGTON BLVD
CITY: STAMFORD
STATE: CT
ZIP: 06901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALEN EMPLOYEE FUND III LP
CENTRAL INDEX KEY: 0001056642
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 13901713
BUSINESS ADDRESS:
STREET 1: 610 FIFTH AVENUE 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 2122184990
MAIL ADDRESS:
STREET 1: 610 FIFTH AVENUE 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALEN PARTNERS INTERNATIONAL III L P
CENTRAL INDEX KEY: 0001034574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 13901714
BUSINESS ADDRESS:
STREET 1: 610 FIFTH AVENUE 5TH FLOOR
STREET 2: C/O GALEN ASSOCIATES
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 2122184990
MAIL ADDRESS:
STREET 1: 610 FIFTH AVENUE 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLAUDIUS LLC
CENTRAL INDEX KEY: 0001056643
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 13901715
BUSINESS ADDRESS:
STREET 1: 610 FIFTH AVENUE 5TH FLOOR
STREET 2: C/O GALEN ASSOCIATES
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 2122184990
MAIL ADDRESS:
STREET 1: C/O GALEN ASSOCIATES
STREET 2: 610 FIFTH AVENUE 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10020
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-06-04
0
0000786947
ACURA PHARMACEUTICALS, INC
ACUR
0001056643
CLAUDIUS LLC
C/O GALEN MANAGEMENT, L.L.C.
680 WASHINGTON BLVD.
STAMFORD
CT
06901
0
0
1
0
0001034574
GALEN PARTNERS INTERNATIONAL III L P
C/O GALEN MANAGEMENT, L.L.C.
680 WASHINGTON BLVD.
STAMFORD
CT
06901
0
0
1
0
0001056642
GALEN EMPLOYEE FUND III LP
C/O GALEN MANAGEMENT L.L.C.
680 WASHINGTON BLVD.
STAMFORD
CT
06901
0
0
1
0
0001421162
Galen Management, LLC
680 WASHINGTON BLVD.
STAMFORD
CT
06901
0
0
1
0
0001034486
GALEN PARTNERS III L P
C/O GALEN MANAGEMENT, L.L.C.
680 WASHINGTON BLVD.
STAMFORD
CT
06901
0
0
1
0
Common Stock
2013-06-04
4
S
0
22802
2.21
D
11822674
I
See FN
Common Stock
2013-06-05
4
S
0
6650
2.21
D
11816024
I
See FN
Common Stock
2013-06-06
4
S
0
10001
2.13
D
11806023
I
See FN
The shares were sold as follows: 20,831 by Galen Partners III, L.P. ("Galen III"), 1,885 by Galen Partners International III, L.P. ("Galen International") and 86 by Galen Employee Fund III, L.P. ("Employee Fund").
The shares were sold at prices between $2.20 and $2.25. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 10,803,732 by Galen III, 974,440 by Galen International and 44,502 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
The shares were sold as follows: 6,075 by Galen III, 550 by Galen International and 25 by Employee Fund.
The shares were sold at prices between $2.20 and $2.245. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 10,797,657 by Galen III, 973,890 by Galen International and 44,477 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
The shares were sold as follows: 9,136 by Galen III, 827 by Galen International and 38 by Employee Fund.
The shares were sold at prices between $2.11 and $2.15. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 10,788,521 by Galen III, 973,063 by Galen International and 44,439 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
/s/ David W. Jahns, Member of Claudius, L.L.C.
2013-06-07
/s/ David W. Jahns, Member of Claudius L.L.C., the General Partner of Galen Partners International III, L.P.
2013-06-07
/s/ David W. Jahns, Member Galen Management, L.L.C., the General Partner of Galen Employee Fund III, L.P.
2013-06-07
/s/ David W. Jahns, Member
2013-06-07
/s/ David W. Jahns, Member of Claudius, L.L.C., the General Partner of Galen Partners III, L.P.
2013-06-07